7.85

1.03% 0.08

After Hours: 7.85

CorMedix Inc (CRMD)

Overview News Price History Option Chain Discussions Forecast Stock Split

CorMedix Inc stock is traded at $7.85, with a volume of 606.56K. It is up +1.03% in the last 24 hours and down -8.29% over the past month. CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.

Previous Close:

$7.77

Open:

$7.79

24h Volume:

606.56K

Relative Volume:

0.52

Market Cap:

$611.86M

Revenue:

$400.05M

Net Income/Loss:

$181.01M

P/E Ratio:

3.7393

EPS:

2.0993

Net Cash Flow:

$194.58M

1W Performance:

+1.68%

1M Performance:

-8.29%

6M Performance:

+18.76%

1Y Performance:

-29.41%

1-Day Range:

$7.69

$7.90

1-Week Range:

$7.62

$8.185

52-Week Range:

$6.125

$13.02

CorMedix Inc Stock (CRMD) Company Profile

Name

CorMedix Inc

Sector

Healthcare (1067)

Industry

Biotechnology (595)

Phone

908-517-9500

Address

400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ

Employee

Twitter

Next Earnings Date

2026-11-11

Latest SEC Filings

CRMD's Discussions on Twitter

Compare CRMD vs VRTX, REGN, MRNA, ARGX, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRMD CorMedix Inc	7.85	611.86M	400.05M	181.01M	194.58M	2.0993
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Upgrade	D. Boral Capital	Hold → Buy
Jun-30-25	Downgrade	D. Boral Capital	Buy → Hold
Jun-30-25	Initiated	H.C. Wainwright	Buy
Mar-07-25	Initiated	Leerink Partners	Outperform
Jan-13-25	Initiated	D. Boral Capital	Buy
Aug-26-24	Initiated	Rodman & Renshaw	Buy
Aug-10-23	Initiated	RBC Capital Mkts	Outperform
Feb-17-21	Initiated	Needham	Buy
Sep-29-20	Initiated	JMP Securities	Mkt Outperform
Sep-21-20	Initiated	Truist	Buy
Dec-18-19	Initiated	B. Riley FBR	Buy
Mar-26-19	Reiterated	H.C. Wainwright	Buy
Dec-06-18	Initiated	ROTH Capital	Buy
Sep-25-17	Reiterated	H.C. Wainwright	Buy
Aug-10-17	Reiterated	Rodman & Renshaw	Buy
May-05-17	Reiterated	Rodman & Renshaw	Buy
Nov-11-16	Reiterated	FBR & Co.	Outperform
Mar-17-16	Reiterated	FBR Capital	Outperform
Mar-03-16	Initiated	FBR Capital	Outperform
Nov-16-15	Reiterated	ROTH Capital	Neutral
Oct-29-15	Reiterated	ROTH Capital	Neutral
May-06-15	Downgrade	ROTH Capital	Buy → Neutral
Dec-08-14	Reiterated	ROTH Capital	Buy
Oct-03-11	Downgrade	Maxim Group	Buy → Hold

View All

CorMedix Inc Stock (CRMD) Latest News

Sep 27, 2026

Form 4 CorMedix Inc For: 27 September By Investing.com - Investing.com UK

Sep 27, 2026

Sep 26, 2026

The Technical Signals Behind (CRMD) That Institutions Follow - Stock Traders Daily

Sep 26, 2026

Sep 25, 2026

CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits

Sep 25, 2026

Sep 24, 2026